Prevention, multidisciplinary care key in sports-related eye injuries

Sports-related ocular injuries represent a significant percentage of ocular trauma cases.
With the growing number of people participating in sports and recreational physical activities, the incidence rate of these injuries is steadily on the rise.
Recent data from Prevent Blindness, based on the National Electronic Injury Surveillance System (NEISS), found that 43,379 sports-related eye injuries were treated in the United States in 2024, a 33% increase from the previous year.
“This trend indicates that there’s not enough attention and focus on eye protection because many of these injuries can be

VIDEO: New oral medications showing promise in psoriasis

Linda Stein Gold, MD, director of dermatology clinical research and division head of dermatology at Henry Ford Health System, discussed some “exciting talks” from Maui Derm 2026 that focused on oral agents for psoriasis.
Although there’s currently an “unmet need for the oral treatment of psoriasis,” two oral TYK2 inhibitors and an oral peptide are showing potential in this space, according to Stein Gold.
“Bottom line was, it’s an exciting time for the treatment of psoriasis,” Stein Gold said in a video interview with Healio. “We have some really exciting new molecules on the horizon, and I

VIDEO: Update on topicals for psoriasis presented at Maui Derm

In this video interview, Linda Stein Gold, MD, director of dermatology clinical research and division head of dermatology at Henry Ford Health System, discussed her presentation on new treatments for psoriasis given at Maui Derm 2026.
The talk mostly focused on topical therapies, such as tapinarof and roflumilast.
“Both of these medications reduce the itch as well as the rash of psoriasis,” she told Healio.
Stein Gold also spoke about some of the off-label uses of non-steroidal topicals in the psoriasis space.

Docetaxel rechallenge an option for metastatic prostate cancer

Docetaxel rechallenge significantly improved survival compared with cabazitaxel in certain men with metastatic castration-resistant prostate cancer.
A retrospective analysis of more than 600 patients found those who stopped docetaxel for reasons other than progression survived approximately 3 months longer if they received a second round of docetaxel treatment than those who began cabazitaxel (Jevtana, Sanofi Genzyme).
“We settled the question as to whether retreatment with docetaxel vs. a switch to cabazitaxel is appropriate,” Matthew B. Rettig, MD, medical director of the prostate cancer

Outbreak of sexually transmitted fungus hits Minnesota

Minnesota health officials have issued a warning on the nation’s “largest known outbreak” of Trichophyton mentagrophytes genotype VII — a sexually transmitted fungus that can cause severe ringworm.
Officials say more than 30 confirmed or suspected cases of T. mentagrophytes genotype VII, also known as TMVII, have clustered around the Twin Cities metro area.
The infection appears as “round, coin-like rashes that are red and irritated, sometimes with bumps and pimples on top,” according to the Minnesota Department of Health, and it can lead to scarring and secondary infections. The rash can be

Keratoconus linked to allergic conjunctivitis in real-world study

Allergic conjunctivitis was linked to a significantly increased risk for keratoconus in a large real-world study published in Contact Lens & Anterior Eye.
“Allergic conjunctivitis is one of the most common ocular conditions worldwide, particularly in children and adolescents — the same population at risk for keratoconus,” study author Zvi Gur, MD, an ophthalmologist at Hadassah Medical Organization, Israel, told Healio. “In clinical practice, we repeatedly see patients with chronic allergy symptoms and significant eye rubbing. This raised a fundamental question: Is

How to deal with drop in reimbursement for vitreoretinal surgery

WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Adrienne W. Scott, MD, FASRS, of The Johns Hopkins Wilmer Eye Institute, discusses the economics of vitreoretinal surgery.
“We need to do complex surgery, but we unfortunately are experiencing decreased reimbursement for this surgery,” she said.
{{VIDEO}}
She offered advice on how to manage equipment and finances at a time when reimbursement for vitreoretinal surgery has decreased.
Scott encouraged ophthalmologists to be familiar with the value of the tools
they commonly use, on the lookout for sustainable options and “flexible

JAK inhibitors should be standard of care for alopecia

MIAMI BEACH, Fla. — Treatment with a JAK inhibitor should be standard of care for any patient with alopecia areata who desires it, even if their hair loss is less than 50%, according to a speaker at South Beach Symposium.
JAK inhibitors have a rapid onset of action and are well tolerated for severe alopecia areata, Ruth Ann Vleugels, MD, MPH, MBA, vice chair for academic affairs at Brigham and Women’s Hospital and program director of the dermatology-rheumatology fellowship program at Harvard Medical School, said during the presentation. When discussing JAK inhibitor treatment with patients who

Food quality matters most in a heart-healthy diet

Adherence to healthier versions of low-fat or low-carb diet patterns may be more cardioprotective compared with focusing on macronutrients or animal or vegetable intake, researchers reported.
A prospective study evaluating the link between low-carb and low-fat diet quality and coronary heart disease among U.S. adults was published in the Journal of the American College of Cardiology.
“Low-carbohydrate and low-fat diets are widely practiced in the U.S., yet the effects of low-carbohydrate and low-fat diets on reducing heart disease risk is a topic of ongoing debate. We designed this study to

Starting hormone therapy later raises cancer, heart attack risk

Women who begin using menopausal hormone therapy at age 65 years or older may have higher risk for cancer and cardiovascular events than those who never use HT, according to data published in Menopause.
In a retrospective cohort analysis of 83,147 women aged 50 years or older in the Clalit Health Services database in Israel, women initiating HT at aged 65 years or older had more than twice as high of a risk for developing cancer or for cerebrovascular accident as women who did not use HT. Alon Carney, MD, family physician at Clalit Health Services and clinical instructor in the department of